Jan-Erik Nyström
Fondateur chez TIRmed Pharma AB
Provenance du réseau au premier degré de Jan-Erik Nyström
Entité | Type d'entité | Industrie | |
---|---|---|---|
TIRmed Pharma AB
TIRmed Pharma AB Pharmaceuticals: MajorHealth Technology TIRmed Pharma AB is engaged in pharmacy services. The company was founded by Jan-Erik Nystroem and Anna-Lena Spetz in 2018 and is headquartered in Bromma, Sweden.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Jan-Erik Nyström via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal | |
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Accuro Immunology AB
Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Stockholm | College/University | Doctorate Degree Corporate Officer/Principal | |
University of Lund | College/University | Undergraduate Degree | |
Faculty of Engineering, Lund University | College/University | Graduate Degree | |
Glucox Biotech AB
Glucox Biotech AB Pharmaceuticals: MajorHealth Technology Glucox Biotech AB is a holding company. It develops clinically applicable therapeutics for treatment of type 2 diabetes; hyperglycaemia, insulin resistance and resulting complications. The firm explores new ideas for the prevention of cellular damage in ischemic stroke and heart infarction, as well the idea behind Glucox Biotech's therapies is to reduce oxidative stress by preventing the intracellular formation of reactive oxygen species. The company was founded by Ellen Mona Gratia Wilcke and Per Ingvar O. Wikström on July 1, 2003 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Founder | |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Centre for Infectious Medicine | Corporate Officer/Principal | ||
BRIGHTER AB (PUBL) | Packaged Software | Corporate Officer/Principal | |
Karolinska University Hospital
Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital. | Hospital/Nursing Management | Corporate Officer/Principal | |
Satila Medtech AB | Director/Board Member | ||
NorInvent AB
NorInvent AB Pharmaceuticals: MajorHealth Technology NorInvent AB engages in the development of drug delivery systems. Its product, XtriG is made up of carbohydrate mixed with drug that easily dissolves in the walls of the mouth making the reaction and absorption factor of the drug faster. The company was founded on September 11, 2014 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Neozeo AB
Neozeo AB Information Technology ServicesTechnology Services Neozeo AB develops blockchain technology. The company is based in Stockholm, Sweden. and has subsidiaries in Latvia. The Swedish company was founded in 2010. The CEO is Petr Vasiliev. | Information Technology Services | Director/Board Member | |
Stockholms universitet Inkubator AB | Investment Managers | Chief Executive Officer | |
STAYBLE THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Torna Kapital AB | Founder | ||
CARBIOTIX AB | Miscellaneous Commercial Services | Director/Board Member | |
QLIFE HOLDING AB | Medical Specialties | Director/Board Member | |
SPERMOSENS AB | Medical Specialties | Director/Board Member | |
Huskvarna Stadshotell AB
Huskvarna Stadshotell AB Hotels/Resorts/Cruise linesConsumer Services Huskvarna Stadshotell AB is a boutique hotel located in Huskvarna, Sweden. The hotel has 35 unique rooms, each designed according to their own theme. The hotel also offers two large conference rooms suitable for presentations, breakfast meetings, and more. The hotel is run by Ida and Jakob since 2012, and they strive to make a difference in their guests' experience. | Hotels/Resorts/Cruise lines | Director/Board Member | |
Town & Country Resorts AB | Director/Board Member | ||
Prefabriken AB | Chief Executive Officer | ||
Qlife ApS | Director/Board Member | ||
Lundgren, Nilsson & Moll AB | Director/Board Member | ||
AB svenska stjärnor
AB svenska stjärnor Investment ManagersFinance AB svenska stjärnor is an asset management company based in Linköping, Sweden. AB svenska stjärnor provides asset management services. The Swedish company was founded in 2018. | Investment Managers | Chairman | |
Redoxis AB
Redoxis AB Medical SpecialtiesHealth Technology Redoxis AB focuses on preclinical drug development and validation in autoimmune diseases. The firm focuses on preclinical development of small molecules that target molecular pathways in the immunological responses associated with autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. The company was founded by David Rikard Martinsson Holmdahl and Jan Peter Olofsson in 2007 and is headquartered in Gothenburg, Sweden. | Medical Specialties | Director/Board Member |
Statistiques
Internationale
Suède | 26 |
Etats-Unis | 3 |
France | 2 |
Danemark | 2 |
Sectorielle
Health Technology | 10 |
Consumer Services | 6 |
Commercial Services | 3 |
Technology Services | 3 |
Finance | 3 |
Opérationnelle
Director/Board Member | 20 |
Corporate Officer/Principal | 8 |
Founder | 3 |
Chief Executive Officer | 3 |
Chairman | 2 |
Relations les plus connectées
Insiders | |
---|---|
John Moll | 14 |
Ellen Mona Gratia Wilcke | 12 |
Anna-Lena Spetz | 7 |
Leo Holmgren | 1 |
- Bourse
- Insiders
- Jan-Erik Nyström
- Connexions Sociétés